Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Colorcon
Express Scripts
Deloitte
Daiichi Sankyo
Queensland Health
Chinese Patent Office
Cipla
AstraZeneca

Generated: December 12, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: ibrutinib

« Back to Dashboard

ibrutinib

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Pharmacyclics Inc IMBRUVICA ibrutinib CAPSULE;ORAL 205552 NDA Pharmacyclics LLC 57962-070-28 28 CAPSULE in 1 BOTTLE, PLASTIC (57962-070-28)
Pharmacyclics Inc IMBRUVICA ibrutinib CAPSULE;ORAL 205552 NDA Pharmacyclics LLC 57962-140-09 90 CAPSULE in 1 BOTTLE, PLASTIC (57962-140-09)
Pharmacyclics Inc IMBRUVICA ibrutinib CAPSULE;ORAL 205552 NDA Pharmacyclics LLC 57962-140-12 120 CAPSULE in 1 BOTTLE, PLASTIC (57962-140-12)
Pharmacyclics Inc IMBRUVICA ibrutinib TABLET;ORAL 210563 NDA Pharmacyclics LLC 57962-014-28 1 BLISTER PACK in 1 CARTON (57962-014-28) > 28 TABLET, FILM COATED in 1 BLISTER PACK
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Citi
Boehringer Ingelheim
Moodys
McKesson
Fuji
McKinsey
Chubb
Merck